CAS: 38336-04-8; 2-(Benzyloxy)-1-Ethanamine

该化合物是一种有机化合物,其特征为有矿物质和乙醚功能组;其特征为与氧原子相连的苯基组,该组与乙胺杂质进一步相连;该结构具有独特的化学特性,包括由矿物质组导致的氢联结潜力,该组可能影响其溶解性和再活性;该复合物质一般无色至浅黄色液体或固体,视其纯度和具体条件而定;在乙醇和二氯甲烷等有机溶剂中可溶解,但因缺水的苯基组而水中溶解性有限. 2-(苯并氧)乙胺可以用于各种化学合成,特别是在制药和农用化学品组的开发中,因为它能够成为更复杂的分子的建筑块.在处理和储存方面,应当参考安全数据,因为任何化学物质都是如此.

结构式图片

欧盟法规

C&L通报

上下游产品

CAS号66021-75-8 2-benzyloxyethy... | CAS号87107-79-7 2-(2-(benzyloxy... | CAS号38336-06-0 N-Benzyl(2-benz... | CAS号100-44-7 氯化苄 | CAS号141-43-5 2-氨基乙醇 | CAS号622-08-2 2-苄氧基乙醇 | CAS号64-19-7 冰醋酸 | CAS号4981-83-3 Benzyl-PEG1-Tos | CAS号58841-52-4 Benzyl-PEG1-Ms | CAS号17229-17-3 苄基-2-氯乙醚 | CAS号78407-19-9 2-is°Cyanatoeth... | CAS号6594-55-4 2-phenylmethoxy... | CAS号918152-14-4 3-nitro-N-(2-ph...

合成工艺路线路线简述

    苄基-2-氯乙醚置于镍 Sodium Azide体系中,用 N,N-二甲基甲酰胺,异丙醇 用作溶剂,化学反应生成2-苄基-1-乙胺
    参考文献:Selective Reduction Of Azides. Improved Preparation Of α,α-Disubstituted Benzylamines
    标题:Selective Reduction Of Azides. Improved Preparation Of α,α-Disubstituted Benzylamines
    摘要:
    Doi:10.1055/s-1978-24654

    海关参考信息

    专利信息


    专利号:US-2012253038-A1
    优先权日:2009-04-13
    标 题:Processes for the synthesis of bazedoxifene acetate and intermediates thereof
    发明人:JOSHI SHREERANG; BHUTA SACHIN; TALUKDAR SANJAY; SAWANT SUDHIR; VENKATRAMAN DEEPAK
    权利人:JOSHI SHREERANG; BHUTA SACHIN; TALUKDAR SANJAY; SAWANT SUDHIR; VENKATRAMAN DEEPAK; SANDOZ AG
    摘要:Efficient processes for the synthesis of pharmaceutically useful compounds such as (1-[4-(2-azepan-1-yl-ethoxy)-benzyl]-2-(4-hydroxy-phenyl)-3-methyl-1H-indol-5-ol acetic acid commonly known as bazedoxifene acetate (Formula IX) using cyanomethoxybenzyl halides of Formula III, where X=Halogens e.g., Cl, F, Br, I; G=Any electron donating or electron withdrawing substituent.

    专利号:US-3985835-A
    优先权日:1973-07-30
    标题 :Halogenated esters of phosphorus-containing acids
    发明人:D ALELIO GAETANO F
    权利人:ALELIO GAETANO F D
    摘要:This invention deals with new phosphorus-containing esters having the formula R'''2NP(O) (ORCX=CXR')2 wherein X represents Cl or Br; R represents a divalent hydrocarbon radical of 1-20 carbon atoms; R' represents H, X or R''; R'' represents a monovalent hydrocarbon radical of 1-20 carbon atoms; R''' represents hydrogen, a monovalent hydrocarbon radical of 1-20 carbon atoms, a divalent saturated aliphatic hydrocarbon group having 5 carbon atoms between valencies and forming a cyclic structure with the N, or a derivative of said monovalent hydrocarbon radical in which the derivative group is hydroxy, NH2, NHR'', NR''2, -NR''''K, R''''NHNHC(O)-, R''''NHC(O)NH-, -(N-R-)n-NR'''' , ¦¦ KK R''COO-, R''CONH- or R''O, R'''' represents hydrogen or R''; n represents an integer having a value of 0-50; and K represents hydrogen, R'' or -P(O) (ORCX=CXR')2. These new esters are useful particularly as fire retardants, agricultural chemicals, fuel additives, plasticizers, monomers and intermediates for the synthesis of other useful derivatives.

    专利号:US-9724682-B2
    优先权日:2013-02-26
    标 题 :Synthesis of acyclic and cyclic amines using iron-catalyzed nitrene group transfer
    发明人:BETLEY THEODORE ALEXANDER; HENNESSY ELISABETH THERESE
    权利人:HARVARD COLLEGE
    摘要:The present invention provides novel synthetic methods for making acyclic secondary amines by reacting an azide with a compound bearing one or more C—H groups, catalyzed by a Fe II -dipyrromethene complex. The acyclic secondary amines are thought to be formed through an intermolecular nitrene transfer. Also provided herein are methods of synthesizing protected (e.g., Boc- or Fmoc-protected) cyclic secondary amines (e.g., 5-, 6-, and 7-membered cyclic secondary amines) by reacting an azide that bears one or more C—H groups, catalyzed by a Fe II -dipyrromethene complex. The protected cyclic secondary amines are thought to be formed through an intramolecular nitrene transfer and may be subsequently deprotected to yield cyclic secondary amines.

    专利号:US-2025188083-A1
    优先权日:2021-06-25
    标 题:Modulators of Histone Acetyltransferase 1 and Methods of Treatment Thereof
    发明人:GRUBER JOSHUA JAMES; LIPCHIK ANDREW; SNYDER MICHAEL P; SCHOW STEVEN R
    权利人:UNIV LELAND STANFORD JUNIOR
    摘要:Small molecules compounds and methods of their synthesis are provided. Small molecules identified can inhibit histone acetyltransferase 1 activity. Formulations and medicaments are also provided that are directed to the treatment of human disorders and conditions, such as, for example, neoplasms, cancers, viral, fungal, and parasitic infections, and aging. Therapeutics are also provided containing a therapeutically effective dose of one or more small molecule compounds, present either as pharmaceutically effective salt or in pure form, including, but not limited to, formulations for oral, intravenous, or intramuscular administration.

    专利号:EP-3904354-A1
    优先权日:2020-04-30
    标 题:New imidazolone derivatives as inhibitors of protein kinases in particular dyrk1a, clk1 and/or clk4
    权利人:PERHA PHARMACEUTICALS
    摘要:The present invention relates to a compound of formula (I)n nwherein R 1 represents a (C 1 -C 6 )alkyl group, a spiro(C 5 -C 11 )bicyclic ring, a fused phenyl group, a substituted phenyl group, a R'-L- group, wherein L is either a single bond or a (Ci-C3)alkanediyl group, and R' represents a (C 3 -C 8 )cycloalkyl group, a bridged (C6-C 10 )cycloalkyl group, a (C 3 -C 8 )heterocycloalkyl group, or a (C 3 -C 8 )heteroaryl group, or a R'-L- group wherein L is a (Ci-C3)alkanediyl group, and R' is a an optionally substituted phenyl group or any of its pharmaceutically acceptable salt. n The present invention further relates to a composition comprising a compound of formula (I) and a process for manufacturing said compound as well as its synthesis intermediates. n It also relates to said compound for use as a medicament, in particular in the treatment and/or prevention of cognitive deficits associated with Down syndrome; Alzheimer's disease; dementia; tauopathies; Parkinson's disease; CDKL5 Deficiency Disorder; Phelan-McDermid syndrome; autism; diabetes; regulation of folate and methionine metabolism; osteoarthritis; Duchenne muscular dystrophy; several cancers; neuroinflammation, anemia and infections and for regulating body temperature.

    专利号:US-5064962-A
    优先权日:1989-02-23
    标题:Diaminothiophenes
    发明人:WIESENFELDT MATTHIAS; ETZBACH KARL-HEINZ
    权利人:BASF AG
    摘要:Diaminothiophenes of the formula or tautomers thereof, where R1 and R2 are each hydrogen or together are where T1 is hydrogen, alkyl or phenyl, T2 and T3 are, independently of one another, alkyl or phenyl, or T2 and T3 together with the nitrogen linking them are a heterocyclic radical, R3 is substituted amino and R4 is alkanoyl, benzoyl, cyano, nitro or where T4 is hydrogen, alkyl or phenyl and T5 is the radical of a primary amine or of an active methylene compound, are prepared as described. The present diaminothiophene compound is useful in the synthesis of dyes, crop protection agents and pharmaceuticals.
    嘉兴市吉拉特化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.jlightchem.com
    企业联系电话:0573-82813637;82813639👤
    📞嘉兴市吉拉特化工有限公司 ⚠️参考联系方式
    联系人:魏经理;王经理;叶经理
    电话:0573-82813637;82813639
    手机:13605839392;15857374971;15157377625
    传真:0573-82813637
    邮箱:sales@jlightchem.com
    通信地址: 浙江省嘉兴市大桥镇嘉兴工业园区东塘支路北侧
    邮编: 314006
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:浙江省嘉兴市大桥镇嘉兴工业园区东塘支路北侧
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    武汉市罗氏科技发展有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.luoshikg.com
    企业联系电话:18986168071;19307247857👤
    📞武汉市罗氏科技发展有限公司 ⚠️参考联系方式
    联系人:罗经理;祝经理
    电话:18986168071;19307247857
    手机:18986168071;19307247857
    传真:027-88121016;QQ1712680783
    邮箱:18986168071@163.com
    通信地址: 湖北省武汉市洪山区洪山工业园
    邮编: 430064
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:湖北省武汉市洪山区洪山工业园
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Wessjohann, L. A.; Kaluđerović, G. N.; Neves Filho, R. A. W.; Morejon, M. C.; Lemanski, G.; Ziegler, T., Science of Synthesis: Multicomponent Reactions, (2013) 1, 449.
    摘要:Monguchi, Y.; Sajiki, H., Science of Synthesis: Catalytic Reduction in Organic Synthesis, (2017) 2, 353.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知